143 related articles for article (PubMed ID: 22434383)
1. Identification of EBP50 as a specific biomarker for carcinogens via the analysis of mouse lymphoma cellular proteome.
Lee YJ; Choi IK; Sheen YY; Park SN; Kwon HJ
Mol Cells; 2012 Mar; 33(3):309-16. PubMed ID: 22434383
[TBL] [Abstract][Full Text] [Related]
2. Moesin is a biomarker for the assessment of genotoxic carcinogens in mouse lymphoma.
Lee YJ; Choi IK; Sheen YY; Park SN; Kwon HJ
Mol Cells; 2012 Feb; 33(2):203-10. PubMed ID: 22358511
[TBL] [Abstract][Full Text] [Related]
3. Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.
Lin YY; Hsu YH; Huang HY; Shann YJ; Huang CY; Wei SC; Chen CL; Jou TS
J Clin Invest; 2012 May; 122(5):1881-94. PubMed ID: 22466651
[TBL] [Abstract][Full Text] [Related]
4. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor function of ezrin-radixin-moesin-binding phosphoprotein-50 through β-catenin/E-cadherin pathway in human hepatocellular cancer.
Peng XL; Ji MY; Yang ZR; Song J; Dong WG
World J Gastroenterol; 2013 Feb; 19(8):1306-13. PubMed ID: 23483729
[TBL] [Abstract][Full Text] [Related]
6. Roles of NHERF1/EBP50 in cancer.
Georgescu MM; Morales FC; Molina JR; Hayashi Y
Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953
[TBL] [Abstract][Full Text] [Related]
7. The tails of apical scaffolding proteins EBP50 and E3KARP regulate their localization and dynamics.
Garbett D; Sauvanet C; Viswanatha R; Bretscher A
Mol Biol Cell; 2013 Nov; 24(21):3381-92. PubMed ID: 23985317
[TBL] [Abstract][Full Text] [Related]
8. EBP50 promotes focal adhesion turnover and vascular smooth muscle cells migration.
Song GJ; Leslie KL; Barrick S; Bougoin S; Taboas JM; Bisello A
J Mol Cell Cardiol; 2012 Dec; 53(6):809-19. PubMed ID: 22974528
[TBL] [Abstract][Full Text] [Related]
9. Binding of EBP50 to Nox organizing subunit p47phox is pivotal to cellular reactive species generation and altered vascular phenotype.
Al Ghouleh I; Meijles DN; Mutchler S; Zhang Q; Sahoo S; Gorelova A; Henrich Amaral J; Rodríguez AI; Mamonova T; Song GJ; Bisello A; Friedman PA; Cifuentes-Pagano ME; Pagano PJ
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):E5308-17. PubMed ID: 27540115
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic EBP50 and elevated PARP1 are unfavorable prognostic factors in ovarian clear cell carcinoma.
Matsumoto T; Yoki A; Konno R; Oguri Y; Hashimura M; Tochimoto M; Nakagawa M; Jiang Z; Ishibashi Y; Ito T; Kodera Y; Saegusa M
Carcinogenesis; 2021 Oct; 42(9):1162-1170. PubMed ID: 34323956
[TBL] [Abstract][Full Text] [Related]
11. Ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) and nuclear factor-κB (NF-κB): a feed-forward loop for systemic and vascular inflammation.
Leslie KL; Song GJ; Barrick S; Wehbi VL; Vilardaga JP; Bauer PM; Bisello A
J Biol Chem; 2013 Dec; 288(51):36426-36. PubMed ID: 24196963
[TBL] [Abstract][Full Text] [Related]
12. The detection of EBP50 expression using quantum dot immunohistochemistry in pancreatic cancer tissue and down-regulated EBP50 effect on PC-2 cells.
Ji MY; Fan DK; Lv XG; Peng XL; Lei XF; Dong WG
J Mol Histol; 2012 Oct; 43(5):517-26. PubMed ID: 22622406
[TBL] [Abstract][Full Text] [Related]
13. Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.
Vaquero J; Nguyen Ho-Bouldoires TH; Clapéron A; Fouassier L
Oncogene; 2017 Jun; 36(22):3067-3079. PubMed ID: 28068322
[TBL] [Abstract][Full Text] [Related]
14. A regulated complex of the scaffolding proteins PDZK1 and EBP50 with ezrin contribute to microvillar organization.
LaLonde DP; Garbett D; Bretscher A
Mol Biol Cell; 2010 May; 21(9):1519-29. PubMed ID: 20237154
[TBL] [Abstract][Full Text] [Related]
15. EBP50 suppresses the proliferation of MCF-7 human breast cancer cells via promoting Beclin-1/p62-mediated lysosomal degradation of c-Myc.
Liu H; Zhao WL; Wang JP; Xin BM; Shao RG
Acta Pharmacol Sin; 2018 Aug; 39(8):1347-1358. PubMed ID: 29283175
[TBL] [Abstract][Full Text] [Related]
16. EBP50 phosphorylation by Cdc2/Cyclin B kinase affects actin cytoskeleton reorganization and regulates functions of human breast cancer cell line MDA-MB-231.
Sun C; Zheng J; Cheng S; Feng D; He J
Mol Cells; 2013 Jul; 36(1):47-54. PubMed ID: 23775624
[TBL] [Abstract][Full Text] [Related]
17. PEX7 and EBP50 target iNOS to the peroxisome in hepatocytes.
Loughran PA; Stolz DB; Barrick SR; Wheeler DS; Friedman PA; Rachubinski RA; Watkins SC; Billiar TR
Nitric Oxide; 2013 May; 31():9-19. PubMed ID: 23474170
[TBL] [Abstract][Full Text] [Related]
18. Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate.
Li JG; Chen C; Liu-Chen LY
J Biol Chem; 2002 Jul; 277(30):27545-52. PubMed ID: 12004055
[TBL] [Abstract][Full Text] [Related]
19. PDZ interactions regulate rapid turnover of the scaffolding protein EBP50 in microvilli.
Garbett D; Bretscher A
J Cell Biol; 2012 Jul; 198(2):195-203. PubMed ID: 22801783
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle dependent association of EBP50 with protein phosphatase 2A in endothelial cells.
Boratkó A; Gergely P; Csortos C
PLoS One; 2012; 7(4):e35595. PubMed ID: 22523604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]